Phase III Study of NRD101: A confirmatory study of NRD101 in patients with periarthritis scapulohumeralis

Trial Profile

Phase III Study of NRD101: A confirmatory study of NRD101 in patients with periarthritis scapulohumeralis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Jul 2017

At a glance

  • Drugs Hyaluronic acid (Primary)
  • Indications Frozen shoulder; Periarthritis
  • Focus Therapeutic Use
  • Sponsors Chugai Pharmaceutical
  • Most Recent Events

    • 10 Jul 2017 Status changed from not yet recruiting to recruiting.
    • 24 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top